Skip to main content
2024 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Sandeep Nema, PhD (he/him/his)

SVP
Saliogen Therapeutics
Lexington, Massachusetts

Sandeep is currently SVP, TechOps at Saliogen Therapeutics where he is responsible for CMC, regulatory, and quality of gene therapy products. Prior to joining SalioGen in 2021, Dr. Nema spent 24 years at Pfizer in Pharmaceutical Development with progressively increased responsibilities leading to the role of Executive Director, Biopharmaceutical Sciences. At Pfizer he was responsible for all pre-proof of concept biologics projects (~50) from discovery up to Phase 3 start. Through his career, he has led various functions including Preformulation, Formulation, Microbiology, Stability and Portfolio Groups. His primary focus in parenteral drug development of multiple modalities - vaccines, small molecules, proteins, cell and gene therapy.
Dr. Nema has several patents, papers, posters and presentations to his credit including co-editing a well-established book “Parenteral Medications”. He has been Steering Committee member of “Handbook of Pharmaceutical Excipients”. Sandeep has been closely associated with the registration and approval of multiple small and large molecule products. Sandeep is past-President of AAPS Sterile Product Focus group, served as a Chairman of the Arden House conference and as the Co-Chair of the AAPS/FDA/USP workshop.
Sandeep is an Adjunct Associate Professor at UT and lectures at UofMS, College of Pharmacy. He is a Regulatory Affairs Certified Professional.

Disclosure information not submitted.

Presentation(s):